Details for New Drug Application (NDA): 216282
✉ Email this page to a colleague
The generic ingredient in DEXAMETHASONE is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.
Summary for 216282
Tradename: | DEXAMETHASONE |
Applicant: | Zydus Lifesciences |
Ingredient: | dexamethasone |
Patents: | 0 |
Pharmacology for NDA: 216282
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 216282
Suppliers and Packaging for NDA: 216282
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEXAMETHASONE | dexamethasone | TABLET;ORAL | 216282 | ANDA | Preferred Pharmaceuticals Inc. | 68788-8763 | 68788-8763-0 | 100 TABLET in 1 BOTTLE (68788-8763-0) |
DEXAMETHASONE | dexamethasone | TABLET;ORAL | 216282 | ANDA | Preferred Pharmaceuticals Inc. | 68788-8763 | 68788-8763-1 | 12 TABLET in 1 BOTTLE (68788-8763-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Feb 7, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.75MG | ||||
Approval Date: | Feb 7, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1.5MG | ||||
Approval Date: | Feb 7, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription